Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.940
+0.100 (5.43%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Palisade Bio Employees
Palisade Bio had 14 employees as of December 31, 2025. The number of employees increased by 6 or 75.00% compared to the previous year.
Employees
14
Change (1Y)
6
Growth (1Y)
75.00%
Revenue / Employee
n/a
Profits / Employee
-$1,725,071
Market Cap
336.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 6 | 75.00% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | -3 | -25.00% |
| Dec 31, 2022 | 12 | -1 | -7.69% |
| Dec 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| OmniAb | 89 |
| SAB Biotherapeutics | 86 |
| Lineage Cell Therapeutics | 77 |
| Upstream Bio | 75 |
| DiaMedica Therapeutics | 35 |
| Inhibikase Therapeutics | 35 |
| Fennec Pharmaceuticals | 35 |
PALI News
- 12 days ago - Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors - GlobeNewsWire
- 14 days ago - Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn's Disease at New York Academy of Sciences Symposium - GlobeNewsWire
- 19 days ago - Palisade Bio Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Palisade Bio Slides: Corporate presentation - Filings
- 27 days ago - Palisade Bio to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Palisade Bio Slides: Corporate presentation - Filings
- 6 weeks ago - Palisade Bio files $300M mixed securities shelf - TheFly
- 6 weeks ago - Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 - GlobeNewsWire